Revolution Medicines (RVMD) Interest & Investment Income (2019 - 2026)

Revolution Medicines' Interest & Investment Income history runs 8 years deep, the most recent figure standing at $19.5 million for Q1 2026.

• In Q1 2026, Interest & Investment Income fell 21.7% year-over-year to $19.5 million; the TTM figure through Mar 2026 stood at $62.0 million (down 29.59% YoY), while the FY2025 annual figure was $90.7 million, up 4.39% from the prior year.
• Interest & Investment Income was $19.5 million for Q1 2026 at Revolution Medicines, down from $21.3 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $24.9 million in Q1 2025 to a low of -$899000.0 in Q2 2025.
• Historically, Interest & Investment Income has averaged $13.6 million across 5 years, with a median of $19.0 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Interest & Investment Income surged 2237.42% in 2023, then sank 104.18% in 2025.
• A 5-year view of Interest & Investment Income shows it stood at $5.1 million in 2022, then surged by 273.78% to $19.0 million in 2023, then grew by 11.85% to $21.2 million in 2024, then gained by 0.32% to $21.3 million in 2025, then retreated by 8.38% to $19.5 million in 2026.
• The last three Interest & Investment Income figures came in at $19.5 million (Q1 2026), $21.3 million (Q4 2025), and $22.1 million (Q3 2025), per Business Quant data.